Literature DB >> 32682698

The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Incident Frailty: An Analysis of the Cardiovascular Health Study (CHS).

O Alison Potok1, Ronit Katz2, Nisha Bansal3, David S Siscovick2, Michelle C Odden4, Joachim H Ix5, Michael G Shlipak6, Dena E Rifkin5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32682698      PMCID： PMC7967899          DOI： 10.1053/j.ajkd.2020.05.018

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  9 in total

1.  Kidney function and prevalent and incident frailty.

Authors:  Lorien S Dalrymple; Ronit Katz; Dena E Rifkin; David Siscovick; Anne B Newman; Linda F Fried; Mark J Sarnak; Michelle C Odden; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

Review 2.  Cystatin C as a biomarker for estimating glomerular filtration rate.

Authors:  Thomas W Ferguson; Paul Komenda; Navdeep Tangri
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

3.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

5.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

6.  Body Mass Index Trajectories in Relation to Change in Lean Mass and Physical Function: The Health, Aging and Body Composition Study.

Authors:  Ilse Reinders; Rachel A Murphy; Kathryn R Martin; Ingeborg A Brouwer; Marjolein Visser; Daniel K White; Anne B Newman; Denise K Houston; Alka M Kanaya; Daniel S Nagin; Tamara B Harris
Journal:  J Am Geriatr Soc       Date:  2015-08       Impact factor: 5.562

7.  Kidney Function Estimated From Cystatin C, But Not Creatinine, Is Related to Objective Tests of Physical Performance in Community-Dwelling Older Adults.

Authors:  Mark Canney; Donal J Sexton; Matthew D L O'Connell; Rose Anne Kenny; Mark A Little; Conall M O'Seaghdha
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-12       Impact factor: 6.053

8.  Cystatin C and the Risk of Frailty and Mortality in Older Men.

Authors:  Allyson Hart; Terri L Blackwell; Misti L Paudel; Brent C Taylor; Eric S Orwoll; Peggy M Cawthon; Kristine E Ensrud
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-07-01       Impact factor: 6.053

9.  Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

Authors:  Andrzej S Krolewski; James H Warram; Carol Forsblom; Adam M Smiles; Lena Thorn; Jan Skupien; Valma Harjutsalo; Robert Stanton; John H Eckfeldt; Lesley A Inker; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2012-07-30       Impact factor: 19.112
  9 in total
  6 in total

1.  Cystatin C in risk prediction after transcatheter aortic valve replacement: a retrospective analysis.

Authors:  Kensuke Kuwabara; Kan Zen; Masaki Yashige; Kazuaki Takamatsu; Nobuyasu Ito; Yoshito Kadoya; Michiyo Yamano; Tetsuhiro Yamano; Takeshi Nakamura; Hitoshi Yaku; Satoaki Matoba
Journal:  ESC Heart Fail       Date:  2022-06-06

2.  The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  O Alison Potok; Joachim H Ix; Michael G Shlipak; Ronit Katz; Amret T Hawfield; Michael V Rocco; Walter T Ambrosius; Monique E Cho; Nicholas M Pajewski; Anjay Rastogi; Dena E Rifkin
Journal:  Am J Kidney Dis       Date:  2020-07-16       Impact factor: 8.860

3.  Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.

Authors:  Debbie C Chen; Michael G Shlipak; Rebecca Scherzer; Scott R Bauer; O Alison Potok; Dena E Rifkin; Joachim H Ix; Anthony N Muiru; Chi-Yuan Hsu; Michelle M Estrella
Journal:  JAMA Netw Open       Date:  2022-02-01

4.  Cystatin C- and Creatinine-Based Glomerular Filtration Rate Estimation Differences and Muscle Quantity and Functional Status in Older Adults: The Health, Aging, and Body Composition Study.

Authors:  O Alison Potok; Joachim H Ix; Michael G Shlipak; Nisha Bansal; Ronit Katz; Stephen B Kritchevsky; Dena E Rifkin
Journal:  Kidney Med       Date:  2022-01-25

5.  Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline.

Authors:  Chenglong Li; Yanjun Ma; Chao Yang; Rong Hua; Wuxiang Xie; Luxia Zhang
Journal:  JAMA Netw Open       Date:  2022-09-01

Review 6.  Assessment of kidney function: clinical indications for measured GFR.

Authors:  Natalie Ebert; Sebastjan Bevc; Arend Bökenkamp; Francois Gaillard; Mads Hornum; Kitty J Jager; Christophe Mariat; Bjørn Odvar Eriksen; Runolfur Palsson; Andrew D Rule; Marco van Londen; Christine White; Elke Schaeffner
Journal:  Clin Kidney J       Date:  2021-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.